(Reuters) - The agency looked in depth at the product after veralipride
was withdrawn from the Spanish market in 2005 because of reports
of serious side effects affecting the nervous system.
The drug is associated with side effects, including
depression, anxiety and tardive dyskinesia -- a movement
disorder which may be long-lasting or irreversible -- both
during and after treatment, the European drugs watchdog said.
Read more at Reuters.com Government Filings News
was withdrawn from the Spanish market in 2005 because of reports
of serious side effects affecting the nervous system.
The drug is associated with side effects, including
depression, anxiety and tardive dyskinesia -- a movement
disorder which may be long-lasting or irreversible -- both
during and after treatment, the European drugs watchdog said.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment